Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
This brief intro explains expense ratios for retirement index funds and why fees matter for long-term growth. Learn how to compare options and keep costs in check.
16,460 articlesA major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Investors are watching flutter (flut) 2026 earnings closely as FanDuel scales in the US and international markets. Th...
Green Court Capital Management just trimmed its New Oriental Education stake, a move that raises questions about EDU'...
Big Tech’s AI investments are driving a potential $700B spend this year. This guide breaks down who wins, how to inve...
Oracle stock falling has investors weighing AI bets against near-term headwinds. This guide breaks down the drivers, ...
Intuitive Machines faced a notable stock slide this week as broader space-sector volatility and milestone timing conc...
Could a little technology change your big financial future? This deep dive explains how nano nuclear energy and small...
Investors chasing income may be chasing sky-high yields that hide fragile payouts. Three BDCs illustrate growing payo...
Stock splits can create catalysts that spark momentum and attract new buyers. This guide explains how the stock-split...
Credit investors are increasingly worried about an AI bubble. A Bank of America survey shows the concern rising fast,...
Nebius stock fell today after the company announced debt issuance to fund its infrastructure push and key AI partners...
Bitcoin surged beyond the $82,000 level this week, reviving bullish chatter while alerting analysts to rising risk as...